No Data
No Data
Express News | Quince Therapeutics: Regains Compliance With Nasdaq Listing Rule 5450(a)(1)
Quince Therapeutics | 10-Q: Q3 2024 Earnings Report
Express News | Quince Therapeutics Q3 EPS $(0.13) Up From $(0.15) YoY
Quince Therapeutics | 8-K: Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
Express News | Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
Press Release: Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
No Data
No Data